Rankings

Market Cap
Revenue
Operating Income
CapEx
Total Assets
Net Assets
Cash on Hand

Sectors

Technology
Healthcare
Financial Services
Consumer Cyclical
Communication Services
Industrials
Consumer Defensive
Energy
Basic Materials
Real Estate
Utilities

Pages

Home
Earnings Calendar
All Sectors
Terms
Privacy

© 2026 Market Cap Arena. All rights reserved.v1.2.31

TBPH FY 2011 Earnings — Theravance Biopharma, Inc. Revenue & Financial Results | Market Cap Arena

TBPHTheravance Biopharma, Inc.

$685M

FY 2011 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$15M

Gross Profit

$11M74.1% margin

Operating Income

-$109M-736.1% margin

Net Income

-$109M-736.1% margin

EPS (Diluted)

$-3.43

Cash Flow

Operating Cash Flow

-$83M

Free Cash Flow

-$87M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$14M

Total Liabilities

$155M

Stockholders' Equity

-$141M

Cash & Equivalents

$0

← FY 2012 All Quarters